New frontiers in translational control of the cancer genome
about
Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.Ribosomal DNA copy number loss and sequence variation in cancerInhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.eEF1Bγ binds the Che-1 and TP53 gene promoters and their transcripts.Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational controlHuman eIF3: from 'blobology' to biological insight.Co-targeting translation and proteasome rapidly kills colon cancer cells with mutant RAS/RAF via ER stress.Molecular profiling of single organelles for quantitative analysis of cellular heterogeneity.Neat1 is a p53-inducible lincRNA essential for transformation suppression.PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer.Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.Generation of ribosome imprinted polymers for sensitive detection of translational responses.Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism.Evidence for the importance of post-transcriptional regulatory changes in ovarian cancer progression and the contribution of miRNAs.Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation.Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.Quantitative time-resolved chemoproteomics reveals that stable O-GlcNAc regulates box C/D snoRNP biogenesis.Somatic mutation driven codon transition bias in human cancer.Translational Control Mechanisms in Persistent Pain.Ribosome biogenesis in cancer: new players and therapeutic avenues.Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL.Targeting RNA helicases in cancer: The translation trap.How Ribosomes Translate Cancer.mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.Translation rewiring at the heart of phenotype switching in melanoma.Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells.Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.The ribosome, (slow) beating heart of cancer (stem) cell.Translatome analysis at the egg-to-embryo transition in sea urchin.Development of a stress response therapy targeting aggressive prostate cancer.Revealing nascent proteomics in signaling pathways and cell differentiation.New frontiers in translational control of the cancer genome.40 Years of Research Put p53 in Translation.Myc, Oncogenic Protein Translation, and the Role of Polyamines.CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATMeIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity
P2860
Q30829456-B7FFA62D-B530-4488-9CDC-5184D654DDAFQ33825098-B56E058D-42D1-46D3-907D-147E785CD4B5Q36368265-23843D68-3B0A-4AB2-91C8-D82677CB6BD4Q37263272-1ED025FB-70EC-4379-B80C-885A6DE44C87Q37435041-3EFCEE66-8321-45F2-B57C-5DE7652536DCQ37644283-5E75D119-A964-4D04-AA4D-2F9355DA9D73Q37705955-06F5E0D6-5423-4448-B9DF-A21E377C4ADFQ38659237-E8E89147-1F2A-4155-93E8-1A4957F6A36FQ38683437-6A709821-4213-4467-B11C-32DE959F60FCQ38698803-1DBAEB4D-AE4B-4C81-BA8C-05DE66ACA78DQ41123932-4E3FFBCA-0804-480B-9CB2-2254A4B3F643Q41141228-14CB50FA-9AE5-446F-867F-E9D9644A222DQ41234060-8F68840A-63BA-4BFB-BF20-0FF28A580907Q41421416-DC7EE3F3-D8C6-445F-9CEA-43F59196766FQ41677083-D942F37E-56D9-434C-9224-7BE42F2188B0Q42200131-C4FA2888-2B0B-4F75-91F4-B90C0895E6FAQ42798614-7A418D4A-5826-48EA-9359-A03D3E58C30CQ47137487-E9460EB3-5F23-4570-9BFB-9DA875C14434Q47220043-BC4B4422-E712-4508-B1E8-88126B6AADA1Q47344527-598CF7FD-C709-49E1-BD77-FC03C307F57DQ47654911-AC053758-52F8-4932-9A61-EE64444597ACQ47719079-2804CC4A-CEA4-4D6D-9D75-1F7EB5630ED6Q47782255-73EB78C5-378F-4C44-9EB9-253D843EF537Q47986450-CFB68132-CC88-47D3-95E3-33739D6598FDQ48027760-BEADD57C-4512-414B-AF79-2D6DC1C4348DQ48212409-99064B5E-2D6B-417D-90E9-56A819DC5AE8Q50321414-82C0B182-BFDE-4D4B-8912-18F3785BC215Q50879143-A36D3C0A-5E25-4A25-B95B-3A78187733D8Q52315005-3C0A53B3-6BA3-496D-A651-D065627DB217Q52585822-3C100124-C0EF-495A-9FDE-ACD31FF6E030Q52714528-CA652871-9304-4607-B585-E6EBDE8FC6AAQ52731168-85D3D7FD-5607-4CFE-A381-45B3A68D855BQ54325851-F7490806-1518-4E19-8274-437D36DD5620Q55188514-48EE6823-740C-4322-B066-2D2269A3E35CQ55414287-361AA48C-07CF-4257-9FA7-8E0B96666818Q58798783-5FB7262C-377B-4EAA-83EB-94D7C9AA6782Q59136306-DC841936-05F6-41D4-BE2B-47BD4608A3BF
P2860
New frontiers in translational control of the cancer genome
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New frontiers in translational control of the cancer genome
@ast
New frontiers in translational control of the cancer genome
@en
type
label
New frontiers in translational control of the cancer genome
@ast
New frontiers in translational control of the cancer genome
@en
prefLabel
New frontiers in translational control of the cancer genome
@ast
New frontiers in translational control of the cancer genome
@en
P2860
P356
P1476
New frontiers in translational control of the cancer genome
@en
P2093
Davide Ruggero
Morgan L Truitt
P2860
P2888
P304
P356
10.1038/NRC.2016.27
P407
P577
2016-04-01T00:00:00Z
P6179
1016974246